A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group has published recommendations for systemic improvements in clinical use and regulatory pre and postmarketing handling of continuous glucose monitoring CGM devices to improve their safety and efficacy in achieving its potential to improve quality of life and health outcomes for more people with diabetes in the December 2017 issue of Diabetes Care.